CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
(in millions)
Net earnings	$ 219	$ 119
Adjustments to reconcile net earnings to operating cash flow:
Depreciation and amortization	53	57
Earnings from equity method investments, net of distributions	(11)	(14)
(Gain) loss on sales of assets	(12)	58
Stock-based compensation	26	37
Deferred taxes	26	(14)
Changes in assets and liabilities	194	(334)
Other	6	(5)
Operating cash flow	501	(96)
INVESTING CASH FLOW
Purchases of marketable securities	(140)	(250)
Proceeds from sales and maturities of marketable securities	118	260
Capital expenditures	(133)	(71)
Proceeds from sales of assets	69	23
Investments in partnerships and joint ventures	(66)	(13)
Other	23	5
Investing cash flow	(129)	(46)
FINANCING CASH FLOW
Purchase and retirement of debt	(44)	(249)
Proceeds from issuance of 2029 Notes, net of issuance costs	0	560
Capped call transaction related to 2029 Notes	0	(73)
Dividends paid on CPS	0	(29)
Make-whole payment on conversion of CPS	0	(27)
Distributions paid to NCI	(8)	(41)
Capital contributions by NCI	0	5
Proceeds from NuScale share issuance (net of issuance fees)	80	0
Other	(6)	(15)
Financing cash flow	22	131
Effect of exchange rate changes on cash	(1)	(7)
Increase (decrease) in cash and cash equivalents	393	(18)
Cash and cash equivalents at beginning of period	2,519	2,439
Cash and cash equivalents at end of period	2,912	2,421
SUPPLEMENTAL INFORMATION:
Cash paid for interest	41	46
Cash paid for income taxes (net of refunds)	$ (42)	$ 129